1 in 6 Gen Z South Koreans took GLP-1 slimming drugs last year: survey

South Korea’s embrace of GLP-1 weight-loss drugs appears particularly pronounced among younger adults, with roughly one in six Gen Z respondents reporting they had used or been prescribed the medication in 2025, according to a new report. The 2026 Korea Wellness Report, released by KB Financial Group on Sunday and c…

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.